4.7 Article

A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib

Journal

CHEMICAL COMMUNICATIONS
Volume 49, Issue 83, Pages 9570-9572

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c3cc45487h

Keywords

-

Funding

  1. Natural Science Foundation of China [21101028]
  2. Major Project of the State Ministry of Science and Technology of China [2011ZX09101-001-04]
  3. Natural Science Foundation of Fujian Province [2012J05021]

Ask authors/readers for more resources

In this study, two phthalocyanine-erlotinib conjugates linked by an oligoethylene glycol chain have been synthesised and fully characterised. Having erlotinib as the targeting moiety, the two conjugates exhibited high specific affinity to HepG2 cancer cells and tumour tissues, therefore leading to high photodynamic activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available